Exagen (XGN)
(Delayed Data from NSDQ)
$3.03 USD
+0.08 (2.71%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $3.10 +0.07 (2.31%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum C VGM
Balance Sheet
Fiscal Year End for Exagen Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 36 | 62 | 99 | 57 | 72 |
Receivables | 7 | 6 | 10 | 9 | 6 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 5 | 4 | 4 | 4 | 3 |
Total Current Assets | 48 | 73 | 113 | 71 | 81 |
Net Property & Equipment | 5 | 8 | 5 | 2 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 6 | 6 | 6 |
Deposits & Other Assets | 1 | 1 | 0 | 0 | 0 |
Total Assets | 57 | 86 | 123 | 78 | 88 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 3 | 2 | 3 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 8 | 5 | 7 | 6 | 4 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 12 | 10 | 9 | 9 | 6 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 19 | 29 | 27 | 27 | 26 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 1 | 1 | 1 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 34 | 44 | 39 | 37 | 33 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 302 | 298 | 293 | 223 | 220 |
Retained Earnings | -279 | -256 | -208 | -181 | -165 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 23 | 42 | 85 | 42 | 56 |
Total Liabilities & Shareholder's Equity | 57 | 86 | 123 | 78 | 88 |
Total Common Equity | 23 | 42 | 85 | 42 | 56 |
Shares Outstanding | 17.00 | 16.20 | 16.10 | 12.60 | 12.50 |
Book Value Per Share | 1.33 | 2.62 | 5.28 | 3.32 | 4.45 |
Fiscal Year End for Exagen Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 24 | 27 | 36 | 28 | 31 |
Receivables | 12 | 11 | 7 | 17 | 16 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 5 | 4 | 5 | 3 | 4 |
Total Current Assets | 41 | 42 | 48 | 49 | 51 |
Net Property & Equipment | 5 | 5 | 5 | 7 | 8 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 1 |
Total Assets | 49 | 51 | 57 | 61 | 64 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 1 | 3 | 2 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 6 | 6 | 8 | 7 | 6 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 9 | 9 | 12 | 10 | 9 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 20 | 19 | 19 | 19 | 19 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 1 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 32 | 31 | 34 | 33 | 32 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 303 | 303 | 302 | 301 | 300 |
Retained Earnings | -286 | -283 | -279 | -274 | -268 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 18 | 20 | 23 | 28 | 32 |
Total Liabilities & Shareholder's Equity | 49 | 51 | 57 | 61 | 64 |
Total Common Equity | 18 | 20 | 23 | 28 | 32 |
Shares Outstanding | 17.30 | 17.30 | 17.00 | 16.80 | 16.80 |
Book Value Per Share | 1.02 | 1.16 | 1.33 | 1.64 | 1.90 |